Hospital.Help

Berlin – There are once again positive voices from the medical profession that prophylaxis against respiratory syncytial viruses (RSV) with the monoclonal antibody Nirsevimab for infants should become a standard service of statutory health insurance (SHI). There is criticism… [weiter lesen]

#RSV #prophylaxis #Doctors #continue #push #separate #remuneration